Recent Finacing
Recent Raise
Angion Biomedica develops ANG-3777, an HGF/c-Met small-molecule mimetic targeting delayed graft function after kidney transplant, acute kidney injury, and chronic kidney disease in Phase II/III trials.
Focus Areas
Total Raised
Funding round
See the team members at Angion.
